《2009CCO肛管鱗狀細胞癌診治指南》內容簡介:
These recommendations apply to ** patients (age ≥18 years) with a primarydiagnosis of biopsy-proven squamous cell cancer of the ** c**, including basaloid,cloacogenic, and transitional cell tumours. These recommendations do not apply to patientswho have previously undergone resection of their tumour.The management of patients wholater develop extra-pelvic metastases is not considered in this guideline.
《2009CCO肛管鱗狀細胞癌診治指南》內容預覽:
RECOMMENDATIONS
For all stages of localized squamous cell cancer of the ** c**, concurrent CT and RT isrecommended over RT alone to improve local control and decrease colostomy rates.
The optimal CT drug combination for squamous cell cancer of the ** c** is 5-fluorouracil (5FU) plus mitomycin C (MMC), given concurrently with radiation treatment.
At this time, induction CT before concurrent CT and RT should be considered aninvestigational approach.
It is the expert opinion of the Gastrointestinal Cancer Disease Site Group (GI DSG) thatHIV-positive patients with squamous cell cancer of the ** c** should be managed inthe same way as patients without known HIV. Treating physicians should be aware that agreater than average risk of toxicity is possible.
點擊下載***:《2009CCO肛管鱗狀細胞癌診治指南》
本共識意見(草案)依據我國胰腺囊性腫瘤的最近研究,并參考國際相關指南和研究...[詳細]
在美國,結直腸癌發(fā)病率占所有癌癥的第四位,而死亡率為第二位。2012年估計...[詳細]